MDMA, Cortisol and Memory

This interventional trial (n=60) investigates the impact of MDMA on memory and cortisol levels in ecstasy users.

Led by Kim Kuypers at Maastricht University, it employs a double-blind, placebo-controlled, crossover design with four treatment conditions. Novice and heavy ecstasy users will be compared, assessing memory performance and neuroendocrine reactions under various conditions.

The study aims to understand the role of cortisol in MDMA-induced memory impairment and how this may vary between genders. Recruitment is ongoing, with anticipated enrolment of 60 participants starting from November 2008.

Topic Healthy Subjects
Compound MDMA Placebo
Country Netherlands
Visit trial

Trial Details



Trial Number

Sponsors & Collaborators

Maastricht University
Maastricht University is host to the psychopharmacology department (Psychopharmacology in Maastricht) where various researchers are investigating the effects of psychedelics.

Data attribution

A large set of the trials in our database are sourced from ClinicalTrials.gov (CTG). We have modified these post to display the information in a more clear format or to correct spelling mistakes. Our database in actively updated and may show a different status (e.g. completed) if we have knowledge of this update (e.g. a published paper on the study) which isn't reflected yet on CTG. If a trial is not sourced from CTG, this is indicated on this page and you can follow the link to the alternative source of information.